Etrych T - Search Results

1

Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release: synthesis and characterization of distribution and tumor accumulation in mice by noninvasive multispectral optical imaging.

Hoffmann S, Vystrčilová L, Ulbrich K, Etrych T, Caysa H, Mueller T, Mäder K. Hoffmann S, et al. Among authors: etrych t. Biomacromolecules. 2012 Mar 12;13(3):652-63. doi: 10.1021/bm2015027. Epub 2012 Feb 10. Biomacromolecules. 2012. PMID: 22263698

2

Characterisation of the binding interaction between poly(L-lysine) and DNA using the fluorescamine assay in the preparation of non-viral gene delivery vectors.

Read ML, Etrych T, Ulbrich K, Seymour LW. Read ML, et al. Among authors: etrych t. FEBS Lett. 1999 Nov 12;461(1-2):96-100. doi: 10.1016/s0014-5793(99)01435-0. FEBS Lett. 1999. PMID: 10561503 Free article.

3

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.

Etrych T, Jelínková M, Ríhová B, Ulbrich K. Etrych T, et al. J Control Release. 2001 May 18;73(1):89-102. doi: 10.1016/s0168-3659(01)00281-4. J Control Release. 2001. PMID: 11337062

4

Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.

Ríhová B, Etrych T, Pechar M, Jelínková M, Stastný M, Hovorka O, Kovár M, Ulbrich K. Ríhová B, et al. Among authors: etrych t. J Control Release. 2001 Jul 6;74(1-3):225-32. doi: 10.1016/s0168-3659(01)00320-0. J Control Release. 2001. PMID: 11489498

5

HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia.

St'astný M, Plocová D, Etrych T, Ulbrich K, Ríhová B. St'astný M, et al. Among authors: etrych t. Eur J Cancer. 2002 Mar;38(4):602-8. doi: 10.1016/s0959-8049(01)00421-x. Eur J Cancer. 2002. PMID: 11872356

6

Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.

Kovár M, Strohalm J, Etrych T, Ulbrich K, Ríhová B. Kovár M, et al. Among authors: etrych t. Bioconjug Chem. 2002 Mar-Apr;13(2):206-15. doi: 10.1021/bc010063m. Bioconjug Chem. 2002. PMID: 11906257

7

Differences in the intracellular fate of free and polymer-bound doxorubicin.

Hovorka O, St'astný M, Etrych T, Subr V, Strohalm J, Ulbrich K, Ríhová B. Hovorka O, et al. Among authors: etrych t. J Control Release. 2002 Apr 23;80(1-3):101-17. doi: 10.1016/s0168-3659(02)00016-0. J Control Release. 2002. PMID: 11943391

8

HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy.

St'astný M, Plocová D, Etrych T, Kovár M, Ulbrich K, Ríhová B. St'astný M, et al. Among authors: etrych t. J Control Release. 2002 May 17;81(1-2):101-11. doi: 10.1016/s0168-3659(02)00047-0. J Control Release. 2002. PMID: 11992683

9

HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.

Ulbrich K, Etrych T, Chytil P, Jelínková M, Ríhová B. Ulbrich K, et al. Among authors: etrych t. J Control Release. 2003 Feb 21;87(1-3):33-47. doi: 10.1016/s0168-3659(02)00348-6. J Control Release. 2003. PMID: 12618021

10

Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data.

Ríhová B, Strohalm J, Prausová J, Kubácková K, Jelínková M, Rozprimová L, Sírová M, Plocová D, Etrych T, Subr V, Mrkvan T, Kovár M, Ulbrich K. Ríhová B, et al. Among authors: etrych t. J Control Release. 2003 Aug 28;91(1-2):1-16. doi: 10.1016/s0168-3659(03)00235-9. J Control Release. 2003. PMID: 12932633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page